Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: 68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone

Fig. 3

A 55-year-old man presented with a persistently elevated prostate-specific (PSA) range of 4.37–6.82 ng/ml over a period of one year. Magnetic resonance imaging (MRI) (A, T2-weight imaging; B, DWI imaging; C, ADC map) didn’t revealed the presence of any malignant lesions. Positron emission tomography/computed tomography (PET/CT) images (D, CT; E, PET; F, fusion) showed intensive prostate-specific membrane antigen (PSMA) uptake in the center gland and right periphery of the prostate (arrows). According to the predictive model, the probability of clinically significant prostate cancer for this lesion is 0.67 (> 0.35). Subsequent prostate biopsy result in a Gleason score 4 + 3 prostate cancer

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us